- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/38 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
Patent holdings for IPC class C07K 16/38
Total number of patents in this class: 254
10-year publication summary
|
21
|
28
|
23
|
23
|
18
|
27
|
27
|
19
|
11
|
7
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1157 |
36 |
| Novo Nordisk A/S | 2286 |
15 |
| Pfizer Inc. | 3380 |
12 |
| ImCare Biotech, LLC, DBA Imcare Biotech | 9 |
7 |
| Bayer HealthCare LLC | 1350 |
6 |
| Daiichi Sankyo Company, Limited | 1874 |
6 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3367 |
6 |
| Bayer AG | 3336 |
5 |
| Translational Sciences Inc. | 10 |
5 |
| Green Cross Corporation | 202 |
4 |
| Rutgers, The State University of New Jersey | 1893 |
4 |
| Suzhou Alphamab Co., Ltd. | 40 |
4 |
| Ampsource Biopharma Shanghai Inc. | 47 |
4 |
| Janssen Pharmaceutica N.V. | 3384 |
3 |
| Takeda Pharmaceutical Company Limited | 2696 |
3 |
| Alexion Pharmaceuticals, Inc. | 637 |
3 |
| Amicus Therapeutics, Inc. | 350 |
3 |
| Hong Guan Ltd. | 11 |
3 |
| IDEXX Laboratories, Inc. | 839 |
3 |
| Katholieke Universiteit Leuven | 1189 |
3 |
| Other owners | 119 |